Skip to main content

GOLDMAN SACHS GROUP INC

Position in NEO — Neogenomics Inc

CIK 886982 NEW YORK, NY

Position in NEO

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$7,446,882
-$9,406,725 QoQ
Shares Held
1,003,623
-30.0% QoQ
Ownership
0.771%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NEO Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $5,828,014,412 across 35 Diagnostics & Research names. NEO ranks #29 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NEO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $7,446,882 1,003,623
2025-12-31 $16,853,607 1,433,130
2025-09-30 $13,929,920 1,804,394
2025-06-30 $10,849,989 1,484,267
2025-03-31 $16,291,671 1,716,720
2024-12-31 $37,755,793 2,291,007
2024-09-30 $36,663,071 2,485,632
2024-06-30 $29,006,011 2,091,277
2024-03-31 $36,430,439 2,317,458
2023-12-31 $37,006,005 2,287,145
2023-09-30 $30,345,771 2,467,136
2023-06-30 $40,507,294 2,520,678
2023-03-31 $42,920,472 2,465,277
2022-12-31 $25,668,701 2,777,998
2022-09-30 $22,815,776 2,649,916
2022-06-30 $27,835,468 3,415,395
2022-03-31 $5,366,119 441,656
2021-12-31 $17,328,079 507,857
2021-09-30 $11,515,755 238,718
2021-06-30 $10,645,573 235,678
2021-03-31 $14,161,097 293,616
2020-12-31 $10,656,011 197,920
2020-09-30 $10,109,813 274,053
2020-06-30 $14,182,705 457,802
2020-03-31 $16,784,670 607,920